One study by Li et al. even demonstrates an ESR1 fusion in endocrine treatment resistant breast cancer, truncating the hormone-binding domain coding exons28, while a later study by Veeraraghavan et al. identified evidence for another type of recurrent ERα-altering gene fusions in this tumor type32. The gene discussed is ESR1; the disease is breast carcinoma.